Alumis Inc. (ALMS) stock
ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.33−0.06 (-1.48%)
Close on Nov 19, 2026Market cap $560.46MP/E –Yield –
Alumis free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Alumis's free cash flow for the twelve months ending Jun 30, 2026 was -$351.80M. For fiscal 2025 it was -$370.18M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$370.18M | – |
| FY2024 | Dec 31, 2024 | -$256.81M | – |
| FY2023 | Dec 31, 2023 | -$134.47M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$81.74M | – |
| Q1 FY2026 | Mar 31, 2026 | -$87.25M | – |
| Q4 FY2025 | Dec 31, 2025 | -$71.91M | – |
| Q3 FY2025 | Sep 30, 2025 | -$110.91M | – |
| Q2 FY2025 | Jun 30, 2025 | -$106.97M | – |
| Q1 FY2025 | Mar 31, 2025 | -$80.39M | – |
| Q4 FY2024 | Dec 31, 2024 | -$75.13M | – |
| Q3 FY2024 | Sep 30, 2024 | -$84.55M | – |
| Q2 FY2024 | Jun 30, 2024 | -$52.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$44.42M | – |
| Q4 FY2023 | Dec 31, 2023 | -$34.94M | – |
| Q3 FY2023 | Sep 30, 2023 | -$35.42M | – |
See a number that looks wrong?